{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,18]],"date-time":"2025-01-18T05:13:41Z","timestamp":1737177221881,"version":"3.33.0"},"reference-count":0,"publisher":"Tunisian Society of Medical Sciences","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tunis Med"],"abstract":"<jats:p>\u00a0\nObjectif : D\u00e9crire les aspects \u00e9pid\u00e9miologiques, cliniques, \u00e9tiologiques et th\u00e9rapeutiques des hypercalc\u00e9mies prises en charge dans le service de rhumatologie du CHU de Cocody.\nM\u00e9thode : \u00c9tude transversale \u00e0 vis\u00e9e descriptive men\u00e9e au service de rhumatologie du CHU de Cocody de janvier 2013 \u00e0 juillet 2022 et portant sur les dossiers des patients ayant une hypercalc\u00e9mie.\nR\u00e9sultats\u00a0: La fr\u00e9quence hospitali\u00e8re des hypercalc\u00e9mies \u00e9tait de 0,88%, soit 60 cas sur 6771 hospitalisations pendant la p\u00e9riode d\u2019\u00e9tude. L\u2019effectif comprenait 35 hommes et 25 femmes (ratio H\/F=1.4), \u00e2g\u00e9s en moyenne de 56\u00b111,52 ans (extr\u00eames de 25 et 80 ans). Le principal motif de consultation en rapport avec la maladie sous-jacente \u00e9tait le syndrome douloureux ost\u00e9oarticulaires. Les signes en rapport avec une hypercalc\u00e9mie symptomatique \u00e9taient digestifs (23,33%), neurologiques (8,33%) et cardiovasculaires (5%). Les principaux signes extra-articulaires \u00e9taient l\u2019asth\u00e9nie (90%) et l\u2019amaigrissement (78,33%). Au plan biologique, on notait un nette pr\u00e9dominance de l\u2019hypercalc\u00e9mie l\u00e9g\u00e8re (76,67%), suivi par l\u2019hypercalc\u00e9mie mod\u00e9r\u00e9e (10%) et l\u2019hypercalc\u00e9mie s\u00e9v\u00e8re (13,33%). Les \u00e9tiologies \u00e9taient domin\u00e9es par le my\u00e9lome multiple (45%), suivi par les m\u00e9tastases osseuses (40 %), les granulomatose (13,33%) et l\u2019hyperparathyro\u00efdie secondaire (1,67%). Les mol\u00e9cules utilis\u00e9es pour le traitement de l\u2019hypercalc\u00e9mie \u00e9taient les cortico\u00efdes et les biophosphonates. L\u2019\u00e9volution avait \u00e9t\u00e9 favorable chez 18,33% des patients, et non pr\u00e9cis\u00e9e dans 66,67% des cas du fait du transfert du patient dans un autre service. On notait 9 d\u00e9c\u00e8s soit 15% des cas.\nConclusion\u00a0: L\u2019hypercalc\u00e9mie est rare et le plus souvent asymptomatique en hospitalisation rhumatologique ....( r\u00e9sum\u00e9 tronqu\u00e9 \u00e0 250 mots).<\/jats:p>","DOI":"10.62438\/tunismed.v102i12.5053","type":"journal-article","created":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:46:49Z","timestamp":1737125209000},"source":"Crossref","is-referenced-by-count":0,"title":["Particularit\u00e9s de l'hypercalc\u00e9mie des patients du CHU de Cocody- C\u00f4te d\u2019Ivoire"],"prefix":"10.62438","volume":"102","author":[{"given":"Abidou Kawele","family":"Coulibaly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aboubakar","family":"Bamba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You Nina Carmelle","family":"Kpami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaya","family":"Coulibaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kouassi Jean-Mermoze","family":"Djaha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadine","family":"Mokam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Diomand\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Gbane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baly","family":"Ouattara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edmond","family":"Eti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"31112","published-online":{"date-parts":[[2024,12,1]]},"container-title":["La Tunisie M\u00e9dicale"],"original-title":[],"deposited":{"date-parts":[[2025,1,17]],"date-time":"2025-01-17T14:46:49Z","timestamp":1737125209000},"score":1,"resource":{"primary":{"URL":"https:\/\/latunisiemedicale.com\/index.php\/tunismed\/article\/view\/5053"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":0,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.62438\/tunismed.v102i12.5053","relation":{},"ISSN":["2724-7031","0041-4131"],"issn-type":[{"value":"2724-7031","type":"electronic"},{"value":"0041-4131","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}